Reassessment of the in vitro synergistic effect of fluconazole with the non-steroidal anti-inflammatory agent ibuprofen against Candida albicans

被引：32

作者：

Arai, R

Sugita, T

Nishikawa, A

机构：

[1] Meiji Pharmaceut Univ, Dept Microbiol, Tokyo 2048588, Japan

[2] Meiji Pharmaceut Univ, Dept Immunobiol, Tokyo 2048588, Japan

来源：

MYCOSES | 2005年 / 48卷 / 01期

关键词：

ibuprofen; fluconazole; synergism; Candida albicans;

D O I：

10.1111/j.1439-0507.2004.01052.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

We reassessed the in vitro synergistic effect of fluconazole with the non-steroidal anti-inflammatory agent ibuprofen against the pathogenic yeast Candida albicans. No synergistic effect of fluconazole combined with ibuprofen was seen against fluconazole-susceptible strains, but a remarkable effect was seen against fluconazole-resistant strains (FIX index: 0.02-0.03). Furthermore, vigorous growth of the microorganism, the so-called 'Eagle effect', was observed at concentrations higher than the minimal inhibitory concentrations of ibuprofen and fluconazole. Our results suggest that the combination of ibuprofen and fluconazole should prove useful for treating infection caused by fluconazole-resistant C. albicans.

引用

收藏

页码：38 / 41

页数：4

相关论文

共 16 条

[1] PHARMACOKINETICS OF IBUPROFEN [J].

ALBERT, KS ;

GERNAAT, CM .

AMERICAN JOURNAL OF MEDICINE, 1984, 77 (1A) :40-46

[2] THE RATE OF BACTERICIDAL ACTION OF PENICILLIN INVITRO AS A FUNCTION OF ITS CONCENTRATION, AND ITS PARADOXICALLY REDUCED ACTIVITY AT HIGH CONCENTRATIONS AGAINST CERTAIN ORGANISMS [J].

EAGLE, H ;

MUSSELMAN, AD .

JOURNAL OF EXPERIMENTAL MEDICINE, 1948, 88 (01) :99-131

[3] Synergic effects of tacrolimus and azole antifungal agents against azole-resistant Candida albicans strains [J].

Maesaki, S ;

Marichal, P ;

Hossain, MA ;

Sanglard, D ;

Vander Bossche, H ;

Kohno, S .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (06) :747-753

[4] Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans [J].

Marchetti, O ;

Moreillon, P ;

Glauser, MP ;

Bille, J ;

Sanglard, D .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) :2373-2381

[5] Synergy of nitric oxide and azoles against Candida species in vitro [J].

McElhaney-Feser, GE ;

Raulli, RE ;

Cihlar, RL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) :2342-2346

[6] Effect of fluvastatin and pravastatin, HMG-CoA reductase inhibitors, on fluconazole activity against Candida albicans [J].

Nash, JD ;

Burgess, DS ;

Talbert, RL .

JOURNAL OF MEDICAL MICROBIOLOGY, 2002, 51 (02) :105-109

[7]

National Committee for Clinical Laboratory Standards, 1997, M27A NAT COMM CLIN L

[8] Deeply invasive candidiasis [J].

Ostrosky-Zeichner, L ;

Rex, JH ;

Bennett, J ;

Kullberg, BJ .

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2002, 16 (04) :821-+

[9] Antifungal activity of ibuprofen alone and in combination with fluconazole against Candida species [J].

Pina-Vaz, C ;

Sansonetty, F ;

Rodrigues, AG ;

Martinez-De-Oliveira, J ;

Fonseca, AF ;

Mårdh, PA .

JOURNAL OF MEDICAL MICROBIOLOGY, 2000, 49 (09) :831-840

[10] Resistance of Candida species to antifungal agents:: molecular mechanisms and clinical consequences [J].

Sanglard, D ;

Odds, FC .

LANCET INFECTIOUS DISEASES, 2002, 2 (02) :73-85